Meet BrosMed at CIRSE 2023
Release time:
2023-09-05
BrosMed Medical is delighted to participate in the CIRSE 2023 Congress from September 9th to 12th in Copenhagen, Denmark.
BrosMed Medical is delighted to participate in the CIRSE 2023 Congress from September 9th to 12th in Copenhagen, Denmark.
We can’t wait to engage with the masters and partners there, as well as showcase our professional toolkit for complex PCI and AVF&PAD solutions, including:
Alveo™ HP CTO Balloon Dilatation Catheter: Smallest ø 0.75mm CTO Balloon in the world
Pronavi™ Microcatheter: Two low-profile options: 1.7F &1.9F, 135cm length for antegrade, 150cm & 162cm length for retrograde
POT™ PTCA NC Balloon Dilatation Catheter: Dedicated balloon for the POT and DOT techniques
Wedge™ NC Scoring PTCA Balloon Dilatation Catheter: Safe and controlled lesion preparation
Tri-Wedge™ PTA Scoring Balloon Catheter: Three triangular metallic wires for precise & effective dilatation in AV Fistula stenosis
Tiche™ High-Pressure PTA Balloon Dilatation Catheter: 0.035” system, deliverable high pressure 24 atm with a low tip entry profile 0.040”
Let’s meet at BrosMed Medical Booth #D67. If you will participate in this fantastic event, please contact us via email: sales@brosmed.com. Looking forward to seeing you there!
ABOUT BROSMED MEDICAL
Founded in 2012, BrosMed is a leading medical device multinational company specializing in R&D, production, and global sales of high-performance intravascular interventional medical devices. We have operated four R&D centers (Labs), and 2 manufacturing centers around China, Europe, and Asia Pacific. BrosMed has more than 20 product series and 360+ product registration certificates worldwide.
Previous Article
Next Article
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
